Chronic disease is dynamic. Clinical decisions should be too.
BioTraject Systems is building the computational operating system for chronic disease care — an integrated platform that organizes longitudinal clinical information into patient-specific views of disease trajectory, uncertainty, and possible future paths.
NephroSync™, the current application, brings this approach to chronic kidney disease.
- Patent-pending architecture
- Built for longitudinal data
- Designed for responsible clinical and research use
Chronic disease cannot be understood from a snapshot.
Measurements change, treatments begin or intensify, and acute events can temporarily disrupt an underlying trajectory. Stage labels, thresholds, and risk scores remain useful, but they may not fully explain what is changing, why it is changing, or what may happen next.
Disease changes over time
The latest value is one point within a longer clinical course.
Patients follow different paths
People with the same diagnosis or stage may progress differently.
Context shapes meaning
Treatment exposure, acute illness, comorbidity, and recent history affect interpretation.
From evolving data to structured decision support.
The BioTraject platform coordinates five broad functions.
- Organize — a time-aware record of measurements, treatments, diagnoses, events, and history.
- Interpret — place changing information within disease-specific clinical context.
- Model — estimate patient-specific disease state, direction, and uncertainty.
- Forecast and compare — evaluate possible future trajectories and clinically bounded scenarios.
- Safeguard — assess whether available information is sufficient and appropriate for interpretation.
Together, these functions turn evolving clinical data into structured, patient-specific decision support.
A computational decision system for chronic kidney disease.
NephroSync is being developed to translate longitudinal CKD information into structured trajectory summaries, risk-driver explanations, scenario comparisons, and visible confidence status. It is designed to support clinical reasoning, monitoring, research, and evidence generation.
- Structured trajectory summaries
- Risk-driver explanations
- Scenario comparisons
- Visible confidence status
- Support for clinical reasoning, monitoring, research, and evidence generation
Risk is one question. Trajectory is the larger story.
Risk prediction asks who may worsen. BioTraject is being developed to help care teams understand how disease is changing, what may be driving the trajectory, what may happen next, and when more information or clinical review is needed before acting.
How disease is changing
Understand the direction and pace of change over time, not just the most recent value.
What may be driving it
Surface the factors contributing most to the current trajectory.
What may happen next
Evaluate possible future paths under defined, clinically bounded scenarios.
When to look closer
Recognize when more information or clinical review is needed before acting.
Built carefully. Evaluated before scale.
BioTraject is being developed around transparent assumptions, clinically bounded scenarios, visible uncertainty, and validation before broader use. The technology is intended to support — not replace — professional clinical judgment and established care standards.
Transparent assumptions
Important assumptions, limitations, and use boundaries remain visible.
Clinically bounded scenarios
Comparisons are framed within defined, clinically reasonable limits.
Validated before scale
Capabilities are evaluated before broader use and designed to support, not replace, professional judgment.
Help build the future of dynamic chronic disease care.
BioTraject welcomes clinical, research, data, technology, and strategic collaborators interested in validation, pilot evaluation, workflow design, evidence generation, implementation, and responsible commercialization.
